ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 939

$728K Total Retail Price of All Prescriptions

Rank: 117 out of 939

448 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 448 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 448 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 9,150 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 815 316 S3 1 1
AMLODIPINE BESYLATE 689 486 2 6
FUROSEMIDE 539 325 3 7
SIMVASTATIN 467 336 4 2
POTASSIUM CHLORIDE 419 234 5 9
GABAPENTIN 371 198 6 11
LISINOPRIL-HYDROCHLOROTHIAZIDE 342 185 7 23
OMEPRAZOLE 337 177 8 5
PRAVASTATIN SODIUM 337 203 8 13
TRAMADOL HCL 321 151 10 16
ZOLPIDEM TARTRATE 314 133 11 20
LEVOTHYROXINE SODIUM 268 164 12 4
METFORMIN HCL 257 152 13 8
LISINOPRIL 249 151 14 3
NEXIUM 241 143 15 18
TIZANIDINE HCL 241 61 15 81
CEPHALEXIN 237 130 17 77
METOPROLOL TARTRATE 199 138 18 10
ATENOLOL 186 108 19 19
MELOXICAM 182 122 20 14
WARFARIN SODIUM 179 130 21 17
CLOPIDOGREL 175 125 22 28
AZITHROMYCIN 174 87 23 32
DIGOXIN 156 95 24 45
SERTRALINE HCL 146 108 25 24
METOPROLOL SUCCINATE 146 84 25 21
ALLOPURINOL 144 86 27 31
INSULIN SYRINGE 141 85 28 97
RANITIDINE HCL 141 48 28 35
TRIAMTERENE-HCTZ 137 77 30 33
TAMSULOSIN HCL 131 103 31 27
PLAVIX 127 83 32 48
GLIMEPIRIDE 124 82 33 37
CEFDINIR 121 75 34 142
AMLODIPINE BESYLATE-BENAZEPRIL 121 98 34 58
CIPROFLOXACIN HCL 120 67 36 54
CARVEDILOL 118 76 37 25
ATORVASTATIN CALCIUM 116 75 38 22
KLOR-CON M20 114 70 39 90
KETOCONAZOLE 114 74 39 229
CLONIDINE HCL 112 50 41 39
LANTUS 111 62 42 59
BISOPROLOL-HYDROCHLOROTHIAZIDE 109 56 43 129
PREDNISONE 107 62 44 42
VENTOLIN HFA 106 52 45 80
TRAZODONE HCL 106 51 45 26
ESTRADIOL 90 51 R 47 79
HYDROCHLOROTHIAZIDE 89 45 48 12
LABETALOL HCL 84 49 49 198
TRIAMCINOLONE ACETONIDE 84 61 49 150
LOSARTAN POTASSIUM 81 27 51 29
CITALOPRAM HBR 78 50 52 15
PROMETHAZINE HCL 78 18 R 52 68
CARISOPRODOL 74 0 R 54 51
NIFEDIPINE ER 74 32 54 105
RAMIPRIL 72 38 56 91
KLOR-CON 10 67 58 57 158
CRESTOR 66 23 58 34
SPIRIVA 63 12 59 73
NAMENDA 63 62 59 49
NEOMYCIN-POLYMYXIN-HC 63 37 59 375
ENALAPRIL MALEATE 61 47 62 65
FELODIPINE ER 61 38 62 255
CYMBALTA 58 15 64 44
METOCLOPRAMIDE HCL 58 24 64 119
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 25 66 64
AMITRIPTYLINE HCL 57 29 R 66 38
LEVOFLOXACIN 57 17 66 86
PAROXETINE HCL 56 32 69 70
ADVAIR DISKUS 56 13 69 60
DILTIAZEM ER 55 37 71 94
PHENYTOIN SODIUM EXTENDED 54 42 72 99
ISOSORBIDE MONONITRATE ER 54 53 72 53
CYCLOBENZAPRINE HCL 54 17 R 72 36
FLUCONAZOLE 53 20 75 140
NATEGLINIDE 53 34 75 333
LYRICA 53 0 75 63
DONEPEZIL HCL 53 53 75 30
LEVEMIR 53 31 75 168
PREMARIN 53 19 R 75 111
ROPINIROLE HCL 52 39 81 78
NYSTATIN 51 27 82 174
BYETTA 51 31 82 319
DIOVAN HCT 51 0 82 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.